 Current status non-insulin-dependent diabetes type II management gliclazide Non-insulin-dependent diabetes NIDDM major cause morbidity mortality worldwide prevalence Western countries insulin secretion diminished tissue insulin sensitivity pathogenesis disease persistent hyperglycemia normalization blood sugar levels Measures hyperglycemia hypertension hyperlipidemia important management NIDDM prevention long-term complications effects dietary modification exercise antihypertensive antiplatelet therapy pharmacologic control blood sugar vascular renal complications NIDDM Gliclazide second-generation sulfonylurea drug efficacy treatment NIDDM combination insulin Studies use gliclazide recent symposia review